Poseida
PSTXPoseida Therapeutics Price (PSTX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
90,185,096
(25.3377)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9,768,000 | 2,985,000 | 0 | 0 | 0 | 31,238 | 130,361,508 | 64,703,000 |
| Net Income | -4,575,000 | -19,662,000 | -44,404,000 | -92,639,000 | 2,452,439 | 4,403,873 | -64,002,000 | -123,430,000 |
| FCF USD | -11,797,000 | -22,898,000 | -39,298,000 | -69,546,000 | -130,236,000 | -105,177,000 | -30,696,000 | -95,233,000 |
| OCF USD | -9,988,000 | -22,697,000 | -38,014,000 | -64,390,000 | -113,328,000 | -102,543,000 | -26,772,000 | -92,167,000 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 1.72 | -0.43 | -0.30 | -0.42 | -0.64 | -1.68 | -0.64 |
| D/E | 0.00 | -0.29 | -0.25 | -0.19 | 0.23 | 0.39 | 0.47 | 0.82 |
| CA/CL | 1.79 | 2.18 | 2.51 | 5.82 | 10.46 | 4.94 | 5.54 | 3.18 |
| TA/TL | 2.39 | 0.43 | 0.37 | 0.50 | 3.39 | 2.38 | 2.14 | 1.61 |
| Total Debt | 0 | 9,708,000 | 19,086,000 | 29,140,000 | 59,315,000 | 61,198,000 | 88,752,000 | 85,423,000 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | -26.64% | -99.15% | -130.23% | -71.46% | 0.68% | 2.09% | -19.52% | -58.09% |
| ROE | -27.87% | 58.62% | 57.88% | 61.96% | 0.94% | 2.82% | -34.12% | -119.02% |
| ROA | 0.00% | -77.25% | -98.41% | -58.86% | -34.93% | -46.41% | -18.19% | -45.07% |
| NM % | -46.84% | -658.69% | - | - | - | 14,097.81% | -49.10% | -190.76% |
| FCF / R% | 0.00% | -767.10% | 0.00% | 0.00% | 0.00% | -336,695.69% | -23.55% | -147.18% |
| FCF / NI% | 257.86% | 116.46% | 88.50% | 80.37% | 100.36% | 84.16% | 47.96% | 77.16% |
| Operating Margin (OM) | 0.00 | -7.13 | - | - | - | -13,024.49 | -3.61 | -9.18 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | -0.08 | -0.49 | -1.24 | -2.33 | 0.07 | 0.07 | -0.89 | -1.37 |
| SPS | 0.16 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 1.81 | 0.72 |
| OCPS | -0.17 | -0.57 | -1.06 | -1.62 | -3.15 | -1.65 | -0.37 | -1.02 |
| FCPS | -0.20 | -0.58 | -1.09 | -1.75 | -3.62 | -1.69 | -0.43 | -1.06 |
| BVPS | 0.28 | -0.84 | -2.14 | -3.76 | 7.28 | 2.51 | 2.61 | 1.15 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.08 | -0.49 | -1.24 | -2.33 | 0.07 | 0.07 | -0.89 | -1.37 |
| CAGR-SPS | 0.16 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 1.81 | 0.72 |
| CAGR-OCPS | -0.17 | -0.57 | -1.06 | -1.62 | -3.15 | -1.65 | -0.37 | -1.02 |
| CAGR-FCPS | -0.20 | -0.58 | -1.09 | -1.75 | -3.62 | -1.69 | -0.43 | -1.06 |
| CAGR-BVPS | 0.28 | -0.84 | -2.14 | -3.76 | 7.28 | 2.51 | 2.61 | 1.15 |